Ainos, Inc.
As of Oct 22, 2026, Ainos is in Stage 4, the downtrend phase, now in week 13 (since Jul 28, 2026). It closed at $0.84, 77.1% below its 52-week high and below its 200-day average, which is falling.
Ainos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is AIMD early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
AIMD among Scientific & Technical Instruments27th of 32 by relative strength
All 32 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | KEYS | Stage 2 · wk 4 | 93 | −11.8% |
| 2 | COHR | Stage 4 · wk 1 | 92 | −30.9% |
| 3 | MLAB | Stage 2 · wk 10 | 90 | −2.9% |
| 4 | VPG | Stage 4 · wk 3 | 85 | −24.5% |
| 5 | ITRN | Stage 4 · wk 2 | 83 | −2.9% |
| 6 | MKSI | Stage 4 · wk 3 | 82 | −25.4% |
| 7 | ST | Stage 3 · wk 11 | 74 | −2.0% |
| 8 | NOVT | Stage 3 · wk 10 | 71 | −5.4% |
| …27 | AIMD | Stage 4 · wk 13 | 12 | −39.5% |
Ainos: quick answers
What stage is Ainos in?
As of Oct 22, 2026, Ainos (AIMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 28, 2026 and is in week 13. What the four stages mean
Is Ainos in an uptrend?
No. Ainos is in a Stage 4 downtrend. It trades 48.2% below its 200-day average, which is falling.
How far is Ainos from its 52-week high?
Ainos closed at $0.84 on Oct 22, 2026, 77.1% below its 52-week high of $3.69. Its 52-week low is $0.84.
How has Ainos performed over the past year?
As of Oct 22, 2026, Ainos is down 76.8% over the past year and down 51.8% so far in 2026.
Which sector and industry is Ainos in?
Ainos is in the Scientific & Technical Instruments industry, part of the Information Technology sector.
About this companyInformation Technology· Scientific & Technical Instruments
Ainos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.